naproxen has been researched along with mannitol in 21 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (mannitol) | Trials (mannitol) | Recent Studies (post-2010) (mannitol) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 13,114 | 685 | 2,583 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 7 (33.33) | 29.6817 |
2010's | 13 (61.90) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Caron, G; Ermondi, G | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Blomquist, L; Henriksson, AE; Johansson, SG; Oman, H | 1 |
Bai, JC; Mauriño, E; Meddings, J; Niveloni, S; Pedreira, S; Smecuol, E; Sugai, E; Vazquez, H | 1 |
Kim, MY; Kim, S; Lee, J; Lee, MK | 1 |
Barratt, MJ; Chang, M; Karim, F; Smith, S; Thorpe, A | 1 |
Bose, S; Figueroa, CE | 1 |
Ji, Y; Paus, R; Prudic, A | 1 |
Bakri, B; Hauck, G; Reich, G; Weimer, M | 1 |
Braig, V; Konnerth, C; Lee, G; Peukert, W | 1 |
1 review(s) available for naproxen and mannitol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for naproxen and mannitol
Article | Year |
---|---|
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Detection of naproxen-induced intestinal permeability change may be facilitated by adding a standardized meal but not by forming marker ratios.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Diet; Drug Interactions; Edetic Acid; Female; Humans; Intestinal Absorption; Male; Mannitol; Middle Aged; Naproxen; Permeability; Reference Values | 1996 |
Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chromatography, High Pressure Liquid; Confidence Intervals; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Female; Gastric Mucosa; Humans; Indomethacin; Intestinal Mucosa; Lactulose; Male; Mannitol; Meloxicam; Middle Aged; Naproxen; Permeability; Pyrazoles; Statistics, Nonparametric; Sucrose; Sulfonamides; Thiazines; Thiazoles | 2001 |
Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cryoprotective Agents; Crystallization; Drug Compounding; Excipients; Freeze Drying; Freezing; Kinetics; Lactose; Mannitol; Nanoparticles; Naproxen; Particle Size; Polyethylene Glycols; Sucrose; Suspensions; X-Ray Diffraction | 2009 |
Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping.
Topics: Administration, Oral; Algorithms; Analgesics; Animals; Behavior, Animal; Disease Models, Animal; Freund's Adjuvant; Ganglia, Spinal; Gene Expression Profiling; Gene Expression Regulation; Injections; Male; Mannitol; Naproxen; Nociceptors; Oleic Acids; Oligonucleotide Array Sequence Analysis; Pain; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Up-Regulation | 2010 |
Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
Topics: Animals; Area Under Curve; Chemistry, Pharmaceutical; Desiccation; Dogs; Drug Stability; Male; Mannitol; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Naproxen; Particle Size; Powders; Solubility; Surface Properties; Technology, Pharmaceutical; X-Ray Diffraction | 2013 |
Influence of excipients on solubility and dissolution of pharmaceuticals.
Topics: Chemistry, Pharmaceutical; Diffusion; Excipients; Indomethacin; Kinetics; Mannitol; Models, Chemical; Models, Statistical; Naproxen; Polyethylene Glycols; Povidone; Solubility; Technology, Pharmaceutical; Viscosity; Water | 2015 |
Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
Topics: Calibration; Carboxymethylcellulose Sodium; Cellulose; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Excipients; Mannitol; Models, Theoretical; Naproxen; Powders; Reproducibility of Results; Spectroscopy, Near-Infrared; Tablets; Technology, Pharmaceutical; Time Factors | 2015 |
Enhanced dissolution of naproxen from pure-drug, crystalline nanoparticles: A case study formulated into spray-dried granules and compressed tablets.
Topics: Chemistry, Pharmaceutical; Crystallization; Excipients; Mannitol; Nanoparticles; Naproxen; Particle Size; Pressure; Solubility; Tablets; Technology, Pharmaceutical | 2019 |